Pharmaceutical Business Review
Drug Discovery & Development
Anonymous User | Login

Novartis To Expand Research In Malaysia

Published: 17-Nov-2009

Research to focus on bioactive compounds

Novartis has signed an agreement with Sarawak Biodiversity Centre (SBC) and BiotechCorp to discover bioactive compounds.

Alexander Jetzer-Chung, director of Novartis said that the memorandum of understanding (MoU) has given the company a chance to leverage on Malaysia's biodiversity for the development of new medical opportunities.

Chung said: "This is bound to be a very effective partnership, especially with the strong support of the Sarawak state government and BiotechCorp"

Under the terms of the agreement, Novartis will offer interships for SBC scientists, including microbiologists and natural products chemists, for them to work at the Novartis Institute for Biomedical Research in Basel, Switzerland, reported Bernama.

Novartis will also provide support to develop bioprospecting activity and will identify new bioactive compounds sourced.

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Vetter Pharma International

High-Quality Aseptically Pre-Filled Injection Systems, Cartridges and Vials ...

Turku Region

A Bright Future in a Great Location ...

TNO

Pharma Services: From Discovery to the Clinic ...

Thomson Reuters

The World's Leading Source of Life Sciences Intelligent Information ...

Thermo Fisher Scientific

The world leader in serving science ...

Tecnosoft

Monitoring Systems for Temperature, Humidity and Pressure ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Water Treatment

From the control room to the downstream processing area and with an eye on utilities servi ...

A Vaccinne Bioassay Case Study – A Successful Strategic Outsourcing Model

Increasingly, pharma and biotech firms are searching for new drivers of revenue and profit ...

USB HotStart-IT for Real Time PCR

USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...

Enabling Drug Delivery Deal Making

Transdermal drug delivery: Time for a closer look. To find out more download this free whi ...

Automating Training Control Processes to Comply with FDA Requirements

Well-managed training programs minimize the risk of non-compliance and improve product qua ...

TNO Pharma Services: From Discovery to the Clinic

Our kinetics & metabolism experts can help you select and further develop your candidate d ...

Related Companies

GlaxoSmithKline plc

GlaxoSmithKline plc (GSK) is a is a United Kingdom-based pharmaceutical, biological, a ...

Merck KGaA

Merck KGaA (Merck) is a Germany-based company engaged in the manufacturing and distribu ...

Wyeth

Wyeth is engaged in developing and providing pharmaceuticals and healthcare products fo ...

Bristol-Myers Squibb Company

Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manuf ...

Johnson & Johnson

Johnson & Johnson (J&J) is engaged in the manufacture and sales of broad range of healt ...

Suppliers Product News

Vetter Dedicates New Facility in Suburban Chicago

The new facility will enable collaboration very early in development process

Pharma Supplier Vetter Shares Pride in Consistent Growth and International Success with Distinguished Visitor Minister zu Guttenberg

Economics and Technology Minister visits global leader's headquarters in southern Germany.

Vetter Packages Success with New Facility

Vetter's new secondary packaging operation allows the company to double its production in half the time.

Finland's Business Environment Ranked Best in the World

The authoritative Economist Intelligence Unit has ranked Finland's business environment as the best in the world for the period 2009-2013.

Finland is the World's Most Prosperous Nation

According to the latest Legatum Prosperity Index, the Finnish economy and society enjoy many of the factors that help drive economic growth and produce happy citizens over the long term. Published for the third time, the Legatum Prosperity Index rates more than 100 nations worldwide according to how well they cultivate empirically-tested drivers of economic and social wellbeing.

Amarna Therapeutics B.V. and TNO Announce SVac Research and Development Partnership

Dutch biotechnology company Amarna Therapeutics B.V. and the Netherlands Organisation for Applied Scientific Research TNO today announced that they have entered into a collaboration agreement to further develop Amarna's viral gene delivery platform SVac.

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address